We help boards and C-suites interpret policy shifts in Washington and Beijing, assess exposure to tariffs, export controls, sanctions, and supply chain regulations, and stress-test commercial strategy across multiple scenarios. Our advisors include former senior U.S. government officials and on-the-ground specialists across Greater China.

We counsel companies entering, expanding, or repositioning in China, with particular focus on navigating rising consumer nationalism, the emergence of high-quality domestic competitors, and the regulatory environment for foreign firms. We also advise Chinese companies pursuing growth in the U.S. market amid heightened scrutiny of investment, technology transfer, and supply chains.

We support cross-border M&A, capital markets transactions, and joint ventures across U.S.-China lines, including CFIUS reviews, National Development and Reform Commission processes, and the stakeholder communications that determine whether deals close on favorable terms.

We work with companies facing entity list designations, sanctions exposure, supply chain investigations, exit ban risk, or politically charged disclosures. Our crisis advisors combine deep market knowledge with experience managing stakeholder pressure across multiple capitals simultaneously.

We advise CEOs and senior leaders communicating with employees, investors, regulators, and the public across both markets, including the framing and sequencing of statements that resonate with one audience while remaining credible to the other.